BSE Live
Nov 25, 16:01Prev. Close
2220.00
Open Price
2222.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 25, 15:59Prev. Close
2222.70
Open Price
2224.00
Bid Price (Qty.)
2241.90 (8)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,390.36 | 2,259.57 | 1,562.84 | 1,797.54 | 1,440.21 | |
| Net CashFlow From Operating Activities | 2,322.16 | 1,982.97 | 1,798.99 | 812.29 | 1,022.33 | |
| Net Cash Used In Investing Activities | -12,114.68 | -1,919.12 | -1,040.61 | -1,369.34 | -1,127.16 | |
| Net Cash Used From Financing Activities | 9,845.34 | -8.68 | -710.41 | 578.92 | 88.87 | |
| Foreign Exchange Gains / Losses | -2.28 | -0.10 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | -61.87 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -11.33 | 55.07 | 47.96 | 21.87 | -15.96 | |
| Cash And Cash Equivalents Begin of Year | 211.62 | 134.13 | 86.17 | 22.58 | 77.50 | |
| Cash And Cash Equivalents End Of Year | 200.29 | 189.20 | 134.13 | 44.45 | 61.53 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y